Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ramanathan

Showing results (231-240 of 302) with videos related to

Pageof 31
Sort By:
Oncogene|February 23, 2016
Threonine 209 phosphorylation on RUNX3 by Pak1 is a molecular switch for its dualistic functionsA Kumar, M Singhal, C Chopra, et al.
Investigational New Drugs|March 1, 2006
Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypesWilliam C Zamboni, Ramesh K Ramanathan, Howard L McLeod, et al.
Genome Medicine|February 4, 2014
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinomaLisa Evers, Pedro A Perez-Mancera, Elizabeth Lenkiewicz, et al.
British Journal of Cancer|September 27, 2017
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignanciesSuresh S Ramalingam, Merrill J Egorin, Ramesh K Ramanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2007
Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignanciesSuresh S Ramalingam, Robert A Parise, Ramesh K Ramanathan, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2009
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancerRamesh K Ramanathan, Chandra P Belani, Deepti A Singh, et al.
British Journal of Cancer|January 24, 2018
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 21, 2015
Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancerGina Song, Teresa K Tarrant, Taylor F White, et al.
British Journal of Cancer|March 13, 2018
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumoursJordan Berlin, Ramesh K Ramanathan, John H Strickler, et al.
Pageof 31

Showing results (231-240 of 302) with videos related to

Sort By:
Pageof 31
Oncogene|February 23, 2016
Threonine 209 phosphorylation on RUNX3 by Pak1 is a molecular switch for its dualistic functionsA Kumar, M Singhal, C Chopra, et al.
Investigational New Drugs|March 1, 2006
Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypesWilliam C Zamboni, Ramesh K Ramanathan, Howard L McLeod, et al.
Genome Medicine|February 4, 2014
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinomaLisa Evers, Pedro A Perez-Mancera, Elizabeth Lenkiewicz, et al.
British Journal of Cancer|September 27, 2017
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A phase I study of 17-allylamino-17-demethoxygeldanamycin combined with paclitaxel in patients with advanced solid malignanciesSuresh S Ramalingam, Merrill J Egorin, Ramesh K Ramanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 19, 2007
Phase I and pharmacokinetic study of vorinostat, a histone deacetylase inhibitor, in combination with carboplatin and paclitaxel for advanced solid malignanciesSuresh S Ramalingam, Robert A Parise, Ramesh K Ramanathan, et al.
Cancer Chemotherapy and Pharmacology|January 27, 2009
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancerRamesh K Ramanathan, Chandra P Belani, Deepti A Singh, et al.
British Journal of Cancer|January 24, 2018
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|June 21, 2015
Roles of chemokines CCL2 and CCL5 in the pharmacokinetics of PEGylated liposomal doxorubicin in vivo and in patients with recurrent epithelial ovarian cancerGina Song, Teresa K Tarrant, Taylor F White, et al.
British Journal of Cancer|March 13, 2018
A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumoursJordan Berlin, Ramesh K Ramanathan, John H Strickler, et al.
Pageof 31